Drugmaker launches litigation against the US government to enable co-payments
According to Reuters, Pfizer Inc. filed a lawsuit on June 26, 2020, to make it possible to help beneficiaries of the federal healthcare program – Medicare – pay for two drugs to treat a rare and sometimes fatal heart disease, and that cost $225,000 a year.